07 September 2021: Original Paper
Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors
Ruoyang Chen BCEF* , Dawei Li BCDFG* , Ming Zhang AC , Xiaodong Yuan ADEF*DOI: 10.12659/AOT.933313
Ann Transplant 2021; 26:e933313
Figure 3 The level of alanine aminotransferase.